Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Halozyme Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $83.8 Mil. Halozyme Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was $1,733.3 Mil.
Therefore, Halozyme Therapeutics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.05.
The historical rank and industry rank for Halozyme Therapeutics's Equity-to-Asset or its related term are showing as below:
HALO'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.12 Med: 0.21 Max: 0.57
Current: 0.05
During the past 13 years, the highest Equity to Asset Ratio of Halozyme Therapeutics was 0.57. The lowest was -0.12. And the median was 0.21.
HALO's Equity-to-Asset is ranked worse than 83.76% of 1564
companies
in the Biotechnology industry
Industry Median: 0.66
vs HALO: 0.05
Halozyme Therapeutics Equity-to-Asset Historical Data
The historical data trend for Halozyme Therapeutics's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Halozyme Therapeutics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Halozyme Therapeutics Equity-to-Asset Distribution
For the Biotechnology industry and Healthcare sector, Halozyme Therapeutics's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Halozyme Therapeutics's Equity-to-Asset falls into.
Halozyme Therapeutics Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Halozyme Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Halozyme Therapeutics Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Halozyme Therapeutics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Halozyme Therapeutics (Halozyme Therapeutics) Business Description
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HALO has been successfully added to your 